Hipp Mark
Known title: DirectorCIK: 0001732778
Associated companies
Transaction History
| CRI | ▲ Buy | Grant | 4,266 | $0 | 5/14/2026 | View on chart |
| CRI | ▲ Buy | Grant | 4,409 | $0 | 5/15/2025 | View on chart |
| CRI | ▲ Buy | Grant | 2,293 | $0 | 5/16/2024 | View on chart |
| CRI | ▼ Sell | Open Market | 1,875 | $153K | 3/6/2024 | View on chart |
| CRI | ▲ Buy | Grant | 2,385 | $0 | 5/18/2023 | View on chart |
| CRI | ▲ Buy | Grant | 1,975 | $0 | 5/19/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Carter's Stock Faces Slip and Lowered Price Target
Recent coverage notes that Carter's shares fell sharply, prompting a price target reduction to $30 by Wells Fargo. Analysts highlighted warning signs in the Russell 2000 and described the stock as potentially undervalued after a 60% decline. The company’s dividend yield of 4.4% and low P/E of 5.9 are cited as attractive income features, while the stock trades near its $37.59 support level.
Carter's Stock Faces Slip and Lowered Price Target. Recent coverage notes that Carter's shares fell sharply, prompting a price target reduction to $30 by Wells Fargo. Analysts highlighted warning signs in the Russell 2000 and described the stock as potentially undervalued after a 60% decline. The company’s dividend yield of 4.4% and low P/E of 5.9 are cited as attractive income features, while the stock trades near its $37.59 support level.